Investor Stock List
Ranked #4,235 of 8,699 institutional investors

DAFNA Capital Management LLC

Los Angeles, CA

$396M
US stock portfolio at live prices · today +$2.6M (+0.67%)
Live prices, last trade 9:49 AM ET
Value at quarter end (Q3 2026)
$468M
Change from Q2 2026
−$56.3M (−10.74%)
Positions
76 · 4 new, 5 sold out
Filed
Nov 16, 2026

Not counted in the ranking: none$25.2M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
RVMD 20.3%ATRC 7.41%XBI 5.53%CMPS 4.41%DNLI 3.45%
StockSharesValue, live% of portfoliovs Q2 2026
RVMD Revolution Medicines, Inc.487,130$80.3M20.3%Reduced −13%
ATRC AtriCure, Inc.522,747$29.3M7.41%Reduced −13%
XBI State Street SPDR S&P Biotech ETF151,505$21.9M5.53%Reduced −23%
CMPS COMPASS Pathways plc2,135,952$17.4M4.41%Added +6%
DNLI Denali Therapeutics Inc.744,014$13.6M3.45%Added +1%
STXS Stereotaxis, Inc.13,680,554$13.5M3.41%Unchanged
IDYA IDEAYA Biosciences, Inc.438,740$11.4M2.89%Reduced −12%
NKTR Nektar Therapeutics323,380$10.3M2.61%Added +2%
AXGN Axogen, Inc.179,960$10.2M2.57%Reduced −14%
NBIX Neurocrine Biosciences, Inc.62,716$9.8M2.49%Added +9%
PODD Insulet Corporation67,870$9.3M2.35%Added +10%
EWTX Edgewise Therapeutics, Inc.221,819$9.1M2.29%Reduced −2%
CYTK Cytokinetics, Incorporated171,998$9.0M2.28%Unchanged
XENE Xenon Pharmaceuticals Inc.204,772$7.7M1.94%Reduced −18%
RCUS Arcus Biosciences, Inc.439,829$7.1M1.78%Reduced −0%
DXCM DexCom, Inc.86,279$7.0M1.77%Unchanged
TNDM Tandem Diabetes Care, Inc.355,208$6.1M1.54%Unchanged
LRMR Larimar Therapeutics, Inc.1,888,155$6.0M1.51%Reduced −6%
KIDS OrthoPediatrics Corp.179,130$5.8M1.47%Reduced −5%
INGN Inogen, Inc.845,179$4.6M1.17%Unchanged
IMVT Immunovant, Inc.135,524$4.4M1.11%Reduced −9%
LKFT Lakefront Biotherapeutics NV130,175$4.4M1.11%Unchanged
STOK Stoke Therapeutics, Inc.146,135$4.0M1.01%Added +12%
NGNE Neurogene Inc.150,532$3.4M0.86%Added +69%
RAPP Rapport Therapeutics, Inc.141,900$3.3M0.84%Added +89%
PRCT PROCEPT BioRobotics Corporation120,000$3.2M0.80%Unchanged
KYMR Kymera Therapeutics, Inc.26,912$3.2M0.80%Reduced −0%
IPSC Century Therapeutics, Inc.2,386,750$3.1M0.78%Reduced −1%
SNDX Syndax Pharmaceuticals, Inc.331,290$3.0M0.76%Reduced −1%
CLDX Celldex Therapeutics, Inc.108,118$3.0M0.75%Added +58%
BCRX BioCryst Pharmaceuticals, Inc.380,248$2.8M0.70%Reduced −5%
BCAX Bicara Therapeutics Inc.299,955$2.7M0.68%Added +5%
EPRX Eupraxia Pharmaceuticals Inc.404,567$2.5M0.63%Added +79%
IBB iShares Biotechnology ETF11,595$2.4M0.60%Reduced −73%
AQST Aquestive Therapeutics, Inc.640,915$2.3M0.58%Reduced −1%
ALGN Align Technology, Inc.14,000$2.3M0.57%Unchanged
ALEC Alector, Inc.908,351$2.2M0.56%Unchanged
RNA Atrium Therapeutics, Inc.300,076$2.2M0.56%Added +134%
ANL Adlai Nortye Group Ltd.232,763$2.1M0.53%Reduced −3%
MAZE Maze Therapeutics, Inc.65,000$2.1M0.53%Unchanged
NGEN NervGen Pharma Corp.810,862$1.5M0.39%Reduced −23%
PROF Profound Medical Corp.225,094$1.5M0.37%Reduced −14%
VKTX Viking Therapeutics, Inc.54,516$1.4M0.36%Reduced −8%
ALLO Allogene Therapeutics, Inc.2,000,000$1.3M0.34%Unchanged
TELA TELA Bio, Inc.1,441,029$1.2M0.29%Unchanged
LXEO Lexeo Therapeutics, Inc.377,059$1.1M0.29%Unchanged
INSP Inspire Medical Systems, Inc.18,200$1.0M0.26%Unchanged
DSGN Design Therapeutics, Inc.102,100$960K0.24%Reduced −0%
MPLT MapLight Therapeutics, Inc.155,579$951K0.24%Reduced −9%
CTMX CytomX Therapeutics, Inc.438,407$905K0.23%Unchanged
RARE Ultragenyx Pharmaceutical Inc.51,100$874K0.22%Added +8%
ANNX Annexon, Inc.257,637$842K0.21%Reduced −13%
QTTB Q32 Bio Inc.98,500$822K0.21%Added +199%
GPCR Structure Therapeutics Inc.46,500$785K0.20%Unchanged
MLYS Mineralys Therapeutics, Inc.44,490$626K0.16%Unchanged
PYXS Pyxis Oncology, Inc.344,820$619K0.16%New
SPRY ARS Pharmaceuticals, Inc.182,785$616K0.16%Added +11%
BNTX BioNTech SE7,000$579K0.15%Unchanged
SPTX Seaport Therapeutics, Inc.32,400$573K0.14%Unchanged
FATE Fate Therapeutics, Inc.500,000$510K0.13%Reduced −5%
BBOT BridgeBio Oncology Therapeutics, Inc.266,038$500K0.13%New
KURA Kura Oncology, Inc.69,068$500K0.13%Reduced −43%
QNRX Quoin Pharmaceuticals, Ltd.132,156$463K0.12%New
SCYX SCYNEXIS, Inc.135,868$351K<0.1%Unchanged
EDIT Editas Medicine, Inc.180,470$310K<0.1%Added +6%
PLRX Pliant Therapeutics, Inc.487,000$292K<0.1%Unchanged
ACET Adicet Bio, Inc.93,812$223K<0.1%Unchanged
CRBP Corbus Pharmaceuticals Holdings, Inc.83,248$198K<0.1%Reduced −23%
AUTL Autolus Therapeutics plc179,316$171K<0.1%Unchanged
FHTX Foghorn Therapeutics Inc.89,659$159K<0.1%Reduced −20%
ENGN enGene Therapeutics Inc.74,650$134K<0.1%Unchanged
IBIO iBio, Inc.170,053$133K<0.1%Unchanged
TNYA Tenaya Therapeutics, Inc.300,000$89K<0.1%Unchanged
KZIA Kazia Therapeutics Limited15,700$83K<0.1%New
VRCA Verrica Pharmaceuticals Inc.23,750$69K<0.1%Unchanged
KARD Kardigan, Inc.5,000$62K<0.1%Unchanged

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
OBIO Orchestra BioMed Holdings, Inc.126,841$890K
MBX MBX Biosciences, Inc.11,809$632K
NVCT Nuvectis Pharma, Inc.20,000$395K
ARTV Artiva Biotherapeutics, Inc.67,101$259K
BCYC Bicycle Therapeutics plc64,492$184K